Brief: Scilex Holding Company Announces Financing Of Up To $25 Million To Enhance Commercialization Of Three FDA Approved Non-Opioid Pain Management Products
21/03/2023 13:07
March 21 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY ANNOUNCES FINANCING OF UP TO $25
MILLION
TO ENHANCE COMMERCIALIZATION OF THREE FDA APPROVED NON-OPIOID
PAIN MANAGEMENT PRODUCTS
* SCILEX HOLDING-ENTERED INTO SECURITIES PURCHASE AGREEMENT
WITH
YA II PN, LTD FOR ISSUANCE, SALE OF UNSECURED CONVERTIBLE
DEBENTURES OF UP TO $25 MILLION
Source text for Eikon: ID:nGNX1dkKr1
Further company coverage: SCLX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing